Nitroglycerin

Nitroglycerin is an organic nitrate ester, a member of the nitrate family of vasodilators that also includes isosorbide dinitrate and isosorbide mononitrate ^[4]. It has an unusual double identity: the very same compound that detonates as an industrial explosive serves, in minute and carefully formulated doses, as a gentle relaxant of blood vessels ^[2]. First synthesized in the mid-nineteenth century, it was adopted as a treatment for angina in the 1870s after the physician William Murrell documented its ability to relieve anginal attacks, and it has remained in continuous clinical use ever since ^[1][2].

Its central role is in the management of angina pectoris, the chest pain that arises when the heart muscle receives too little oxygen ^[1]. It is also used more broadly across cardiovascular emergencies, including acute coronary syndromes, acute heart failure with pulmonary edema, and hypertensive crises, and it has additional uses outside the heart, such as relaxing the smooth muscle of anal fissures ^[1][3]. In the emergency setting it is valued as a fast-acting agent that can be titrated closely to a patient's response ^[3].

Because it is absorbed readily across mucous membranes and the skin, nitroglycerin is available in an unusually wide range of preparations: sublingual tablets and sprays for rapid relief, buccal tablets, transdermal ointments and patches for sustained effect, and intravenous solutions for hospital use ^[1][3]. At lower doses it acts mainly on the veins to reduce the volume of blood returning to the heart, and at higher doses it also dilates arteries, together lessening the heart's workload and its demand for oxygen ^[3].

A defining practical problem with nitroglycerin is the development of tolerance. When the drug is present continuously, its effect fades within a matter of weeks, so dosing schedules are usually designed to include a daily nitrate-free interval during which the medication is absent, allowing responsiveness to recover ^[1]. No pharmacologic agent is currently recommended to prevent this tolerance, and the timed dosing strategy remains the accepted approach ^[1].

Nitroglycerin is a prescription medicine, and its most important safety consideration is a potentially dangerous interaction. Taken together with erectile-dysfunction drugs of the phosphodiesterase-5 inhibitor class, such as sildenafil, it can cause a severe and even life-threatening fall in blood pressure, so the combination is avoided ^[1].

Nitroglycerin is prescription only. Its most common effect is a throbbing headache from blood vessel dilation, along with dizziness, flushing, low blood pressure, and reflex fast heartbeat; fainting can occur if someone stands too quickly. The most dangerous interaction is with erectile dysfunction drugs such as sildenafil and tadalafil, which also boost cyclic GMP and can cause a catastrophic drop in blood pressure when combined. It is avoided in severe low blood pressure, right-sided heart attack, high pressure inside the skull, and severe aortic narrowing. Continuous use breeds tolerance, so patches and long-acting forms need a nitrate-free window each day. Do not stop long-term nitrates abruptly, since that can trigger rebound spasm. Store sublingual tablets tightly closed because they lose potency with air and light.

The interaction that kills is with PDE5 inhibitors. Nitroglycerin donates nitric oxide, raising cyclic GMP in vascular smooth muscle; sildenafil, tadalafil, vardenafil and avanafil block the enzyme that degrades that same cyclic GMP. Together they produce profound, prolonged hypotension that responds poorly to fluids or pressors, and the combination is an absolute contraindication rather than a caution. The overlap window runs roughly 24 hours for sildenafil and vardenafil and around 48 hours for tadalafil. Riociguat, which stimulates soluble guanylate cyclase directly, is contraindicated for the same reason.

Everything else is additive vasodilation. Other antihypertensives, calcium channel blockers, alcohol and tricyclic antidepressants deepen the fall in blood pressure and the risk of syncope.

Ergot alkaloids are a smaller but genuine problem; nitroglycerin increases dihydroergotamine exposure, and ergot vasoconstriction opposes the coronary dilation nitroglycerin is being given for.

Checking a whole stack? Run it through interactions + stacks.

Nitroglycerin was first prepared in 1847 by the Italian chemist Ascanio Sobrero at the University of Turin, who observed that a trace placed on the tongue produced a violent, pounding headache; an early clue to its vascular action. Its explosive power was later harnessed industrially by Alfred Nobel, whose manufacturing fortune ultimately endowed the Nobel Prizes. The therapeutic use for angina was established by the English physician William Murrell, who described its relief of anginal chest pain in The Lancet in 1879, building on earlier work by Thomas Lauder Brunton with the related agent amyl nitrite. It has remained in continuous clinical use ever since, making it one of the oldest cardiovascular drugs still routinely prescribed. Its molecular mechanism, conversion within the body to nitric oxide, was only fully clarified more than a century after its introduction.

Nitroglycerin holds an almost legendary place in cardiovascular medicine as the fast, reliable answer to the crushing pain of angina. A tablet or spray under the tongue can relieve an anginal attack within minutes, and generations of patients and physicians have depended on it as a cornerstone of care for nearly 150 years. Its effectiveness, low cost, and many convenient forms, from sublingual tablets and sprays to ointments, patches, and intravenous solutions, underpin an enduring reputation. The honest caveats are familiar; continuous exposure leads to tolerance that blunts its effect, it commonly causes headaches and light-headedness, and it must never be combined with PDE5 inhibitors such as sildenafil or tadalafil. Even so, as one of the oldest drugs still in daily use, it remains genuinely indispensable.